Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

Assessment of vaccines to be finalised

Assessment of vaccines to be finalised

THE World Health Organization expects to release its assessments for emergency use listing of the two main Chinese vaccines for COVID-19 as well as the Moderna shot by the end of next week, according to WHO Assistant Director-General Mariangela Simao. Simao said the WHO's independent panel was assessing the Moderna vaccine and a vaccine from China's Sinopharm on Friday and was due to look at China's other main vaccine, made by Sinovac Biotech, next week. "So, by the beginning of next week or the end of next week we will have the final assessment of these three vaccines out," she…
Read More
Global reaction to Moderna says its vaccine is 94.5% effective in preventing COVID-19

Global reaction to Moderna says its vaccine is 94.5% effective in preventing COVID-19

MODERNA has revealed that its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company in a week to report results that far exceed expectations. Following are reactions to the news. WALID GELLAD, PROFESSOR OF MEDICINE, UNIVERSITY OF PITTSBURGH, PENNSYLVANIA "Now we know that the vaccine appears to be highly effective. It also seems like we really need the vaccine right now, because we have no coherent national strategy. And the next two months are looking dismal. So there, there has to be some willingness for uncertainty and…
Read More
2nd COVID-19 breakthrough: Moderna vaccine success gives world more hope

2nd COVID-19 breakthrough: Moderna vaccine success gives world more hope

JULIE STEENHUYSEN and MICHAEL ERMAN  MODERNA Inc's experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company has announced, becoming the second U.S. drugmaker to report results that far exceed expectations. Together with Pfizer Inc's vaccine, which is also more than 90% effective, and pending more safety data and regulatory review, the United States could have two vaccines authorized for emergency use in December with as many as 60 million doses of vaccine available this year. Next year, the U.S. government could have access to more than 1 billion doses just from…
Read More